abstract |
The invention discloses a scar and tissue fibration resistant oligomeric double-stranded nucleotide medicine. The sequence of the nucleotide medicine comprises TGACTCA, TTACCTCA, AGCCAGACA and ATGCAGACA nucleic acid sequences or functional equivalents thereof, and the above four core nucleic acid sequences are contained in the sense strand or the antisense strand of the double-stranded decoy nucleotide. |